Tanner Pharma Group

Executive Summary

Tanner Pharma Group is a global specialty pharmaceutical services company headquartered in Lausanne, Switzerland, founded in 2002. It operates through three core divisions—Access Solutions, Clinical Solutions, and International Commercialization—to connect patients in over 120 countries with life-saving and life-improving medicines, particularly in underserved regions. By leveraging its expertise in regulatory navigation, logistics, and commercialization, Tanner Pharma addresses critical gaps in drug availability worldwide. As a private company currently at a Phase 1 development stage, its growth trajectory hinges on expanding service contracts, forging strategic partnerships, and entering new geographies. While the company has an established global network and a track record of facilitating patient access, its near-term visibility is limited due to the lack of publicly disclosed revenue or specific product catalysts. The conviction score reflects a balanced view: steady operational foundation but modest speculative upside without clearer catalysts.

Upcoming Catalysts (preview)

• TBDExpansion into new emerging markets (e.g., Africa, Southeast Asia) for Access Solutions60% success
• TBDStrategic partnership with a major pharmaceutical company for Clinical Solutions services50% success
• TBDLaunch of a proprietary digital platform to streamline patient access and real-world data collection40% success